ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sterile Injectable CDMO Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-24O17035
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sterile Injectable CDMO Market Research Report 2024
BUY CHAPTERS

Global Sterile Injectable CDMO Market Research Report 2024

Code: QYRE-Auto-24O17035
Report
May 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Famar
Pfizer Inc
Quotient Sciences
Temad
Tianjin Hankang Pharmaceutical Biotechnology
Fareva
Sharp
Astral SteriTech
Evonik
Aurigene Pharmaceutical Services
Ethypharm
TriRx Pharmaceutical Services
Gensenta Pharmaceuticals
Flagship Biotech International Pvt Ltd
Curida AS
Polfa Tarchomin
Prague Scientific
Biophrama Group
BioTechnique
Mithra CDMo
S.C. Rompharm Company SRL
BirgiMefar Group
Brooks Laboratories Limited

Sterile Injectable CDMO Market

A Contract Development and Manufacturing Organization (CDMO) that specializes in sterile injectables focuses on the development and manufacturing of injectable drugs in a sterile environment. These organizations typically offer services ranging from formulation development to final sterile fill and finish. They adhere to strict regulatory standards to ensure the safety, efficacy, and quality of the injectable products they produce. Sterile injectables are crucial for various medical applications, including intravenous, intramuscular, and subcutaneous administration of medications. A CDMO specializing in this area plays a vital role in bringing these essential pharmaceutical products to market.
The global Sterile Injectable CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Sterile Injectable CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sterile Injectable CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Sterile Injectable CDMO in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Sterile Injectable CDMO include Abbvie, Famar, Polfa Tarchomin, Pfizer, Quotient Sciences, Temad Co., Tianjin Hankang Pharmaceutical Biotechnology, Fareva, Sharp, Astral SteriTech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sterile Injectable CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Injectable CDMO.
The Sterile Injectable CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sterile Injectable CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Injectable CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Sterile Injectable CDMO Market Report

Report Metric Details
Report Name Sterile Injectable CDMO Market
Segment by Type
  • Preclinical Manufacturing
  • Clinical Manufacturing
  • Commercial Manufacturing
Segment by Application
  • Pharmaceutical Company
  • Research Institute
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbvie, Famar, Polfa Tarchomin, Pfizer, Quotient Sciences, Temad Co., Tianjin Hankang Pharmaceutical Biotechnology, Fareva, Sharp, Astral SteriTech, Evonik, Aurigene Pharmaceutical Services, Prague Scientific, Ethypharm, TriRx Pharmaceutical Services, Biophrama Group, Gensenta Pharmaceuticals, BioTechnique, Mithra CDMo, S.C. Rompharm Company SRL, Flagship Biotech International Pvt. Ltd, Curida AS, BirgiMefar Group, Brooks Laboratories Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sterile Injectable CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sterile Injectable CDMO Market report?

Ans: The main players in the Sterile Injectable CDMO Market are Abbvie, Famar, Polfa Tarchomin, Pfizer, Quotient Sciences, Temad Co., Tianjin Hankang Pharmaceutical Biotechnology, Fareva, Sharp, Astral SteriTech, Evonik, Aurigene Pharmaceutical Services, Prague Scientific, Ethypharm, TriRx Pharmaceutical Services, Biophrama Group, Gensenta Pharmaceuticals, BioTechnique, Mithra CDMo, S.C. Rompharm Company SRL, Flagship Biotech International Pvt. Ltd, Curida AS, BirgiMefar Group, Brooks Laboratories Limited

What are the Application segmentation covered in the Sterile Injectable CDMO Market report?

Ans: The Applications covered in the Sterile Injectable CDMO Market report are Pharmaceutical Company, Research Institute, Other

What are the Type segmentation covered in the Sterile Injectable CDMO Market report?

Ans: The Types covered in the Sterile Injectable CDMO Market report are Preclinical Manufacturing, Clinical Manufacturing, Commercial Manufacturing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sterile Injectable CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Preclinical Manufacturing
1.2.3 Clinical Manufacturing
1.2.4 Commercial Manufacturing
1.3 Market by Application
1.3.1 Global Sterile Injectable CDMO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sterile Injectable CDMO Market Perspective (2019-2030)
2.2 Global Sterile Injectable CDMO Growth Trends by Region
2.2.1 Global Sterile Injectable CDMO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sterile Injectable CDMO Historic Market Size by Region (2019-2024)
2.2.3 Sterile Injectable CDMO Forecasted Market Size by Region (2025-2030)
2.3 Sterile Injectable CDMO Market Dynamics
2.3.1 Sterile Injectable CDMO Industry Trends
2.3.2 Sterile Injectable CDMO Market Drivers
2.3.3 Sterile Injectable CDMO Market Challenges
2.3.4 Sterile Injectable CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sterile Injectable CDMO Players by Revenue
3.1.1 Global Top Sterile Injectable CDMO Players by Revenue (2019-2024)
3.1.2 Global Sterile Injectable CDMO Revenue Market Share by Players (2019-2024)
3.2 Global Sterile Injectable CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sterile Injectable CDMO Revenue
3.4 Global Sterile Injectable CDMO Market Concentration Ratio
3.4.1 Global Sterile Injectable CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sterile Injectable CDMO Revenue in 2023
3.5 Global Key Players of Sterile Injectable CDMO Head office and Area Served
3.6 Global Key Players of Sterile Injectable CDMO, Product and Application
3.7 Global Key Players of Sterile Injectable CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sterile Injectable CDMO Breakdown Data by Type
4.1 Global Sterile Injectable CDMO Historic Market Size by Type (2019-2024)
4.2 Global Sterile Injectable CDMO Forecasted Market Size by Type (2025-2030)
5 Sterile Injectable CDMO Breakdown Data by Application
5.1 Global Sterile Injectable CDMO Historic Market Size by Application (2019-2024)
5.2 Global Sterile Injectable CDMO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sterile Injectable CDMO Market Size (2019-2030)
6.2 North America Sterile Injectable CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sterile Injectable CDMO Market Size by Country (2019-2024)
6.4 North America Sterile Injectable CDMO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sterile Injectable CDMO Market Size (2019-2030)
7.2 Europe Sterile Injectable CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sterile Injectable CDMO Market Size by Country (2019-2024)
7.4 Europe Sterile Injectable CDMO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sterile Injectable CDMO Market Size (2019-2030)
8.2 Asia-Pacific Sterile Injectable CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sterile Injectable CDMO Market Size by Region (2019-2024)
8.4 Asia-Pacific Sterile Injectable CDMO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sterile Injectable CDMO Market Size (2019-2030)
9.2 Latin America Sterile Injectable CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sterile Injectable CDMO Market Size by Country (2019-2024)
9.4 Latin America Sterile Injectable CDMO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sterile Injectable CDMO Market Size (2019-2030)
10.2 Middle East & Africa Sterile Injectable CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sterile Injectable CDMO Market Size by Country (2019-2024)
10.4 Middle East & Africa Sterile Injectable CDMO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Sterile Injectable CDMO Introduction
11.1.4 Abbvie Revenue in Sterile Injectable CDMO Business (2019-2024)
11.1.5 Abbvie Recent Development
11.2 Famar
11.2.1 Famar Company Details
11.2.2 Famar Business Overview
11.2.3 Famar Sterile Injectable CDMO Introduction
11.2.4 Famar Revenue in Sterile Injectable CDMO Business (2019-2024)
11.2.5 Famar Recent Development
11.3 Polfa Tarchomin
11.3.1 Polfa Tarchomin Company Details
11.3.2 Polfa Tarchomin Business Overview
11.3.3 Polfa Tarchomin Sterile Injectable CDMO Introduction
11.3.4 Polfa Tarchomin Revenue in Sterile Injectable CDMO Business (2019-2024)
11.3.5 Polfa Tarchomin Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Sterile Injectable CDMO Introduction
11.4.4 Pfizer Revenue in Sterile Injectable CDMO Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Quotient Sciences
11.5.1 Quotient Sciences Company Details
11.5.2 Quotient Sciences Business Overview
11.5.3 Quotient Sciences Sterile Injectable CDMO Introduction
11.5.4 Quotient Sciences Revenue in Sterile Injectable CDMO Business (2019-2024)
11.5.5 Quotient Sciences Recent Development
11.6 Temad Co.
11.6.1 Temad Co. Company Details
11.6.2 Temad Co. Business Overview
11.6.3 Temad Co. Sterile Injectable CDMO Introduction
11.6.4 Temad Co. Revenue in Sterile Injectable CDMO Business (2019-2024)
11.6.5 Temad Co. Recent Development
11.7 Tianjin Hankang Pharmaceutical Biotechnology
11.7.1 Tianjin Hankang Pharmaceutical Biotechnology Company Details
11.7.2 Tianjin Hankang Pharmaceutical Biotechnology Business Overview
11.7.3 Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Introduction
11.7.4 Tianjin Hankang Pharmaceutical Biotechnology Revenue in Sterile Injectable CDMO Business (2019-2024)
11.7.5 Tianjin Hankang Pharmaceutical Biotechnology Recent Development
11.8 Fareva
11.8.1 Fareva Company Details
11.8.2 Fareva Business Overview
11.8.3 Fareva Sterile Injectable CDMO Introduction
11.8.4 Fareva Revenue in Sterile Injectable CDMO Business (2019-2024)
11.8.5 Fareva Recent Development
11.9 Sharp
11.9.1 Sharp Company Details
11.9.2 Sharp Business Overview
11.9.3 Sharp Sterile Injectable CDMO Introduction
11.9.4 Sharp Revenue in Sterile Injectable CDMO Business (2019-2024)
11.9.5 Sharp Recent Development
11.10 Astral SteriTech
11.10.1 Astral SteriTech Company Details
11.10.2 Astral SteriTech Business Overview
11.10.3 Astral SteriTech Sterile Injectable CDMO Introduction
11.10.4 Astral SteriTech Revenue in Sterile Injectable CDMO Business (2019-2024)
11.10.5 Astral SteriTech Recent Development
11.11 Evonik
11.11.1 Evonik Company Details
11.11.2 Evonik Business Overview
11.11.3 Evonik Sterile Injectable CDMO Introduction
11.11.4 Evonik Revenue in Sterile Injectable CDMO Business (2019-2024)
11.11.5 Evonik Recent Development
11.12 Aurigene Pharmaceutical Services
11.12.1 Aurigene Pharmaceutical Services Company Details
11.12.2 Aurigene Pharmaceutical Services Business Overview
11.12.3 Aurigene Pharmaceutical Services Sterile Injectable CDMO Introduction
11.12.4 Aurigene Pharmaceutical Services Revenue in Sterile Injectable CDMO Business (2019-2024)
11.12.5 Aurigene Pharmaceutical Services Recent Development
11.13 Prague Scientific
11.13.1 Prague Scientific Company Details
11.13.2 Prague Scientific Business Overview
11.13.3 Prague Scientific Sterile Injectable CDMO Introduction
11.13.4 Prague Scientific Revenue in Sterile Injectable CDMO Business (2019-2024)
11.13.5 Prague Scientific Recent Development
11.14 Ethypharm
11.14.1 Ethypharm Company Details
11.14.2 Ethypharm Business Overview
11.14.3 Ethypharm Sterile Injectable CDMO Introduction
11.14.4 Ethypharm Revenue in Sterile Injectable CDMO Business (2019-2024)
11.14.5 Ethypharm Recent Development
11.15 TriRx Pharmaceutical Services
11.15.1 TriRx Pharmaceutical Services Company Details
11.15.2 TriRx Pharmaceutical Services Business Overview
11.15.3 TriRx Pharmaceutical Services Sterile Injectable CDMO Introduction
11.15.4 TriRx Pharmaceutical Services Revenue in Sterile Injectable CDMO Business (2019-2024)
11.15.5 TriRx Pharmaceutical Services Recent Development
11.16 Biophrama Group
11.16.1 Biophrama Group Company Details
11.16.2 Biophrama Group Business Overview
11.16.3 Biophrama Group Sterile Injectable CDMO Introduction
11.16.4 Biophrama Group Revenue in Sterile Injectable CDMO Business (2019-2024)
11.16.5 Biophrama Group Recent Development
11.17 Gensenta Pharmaceuticals
11.17.1 Gensenta Pharmaceuticals Company Details
11.17.2 Gensenta Pharmaceuticals Business Overview
11.17.3 Gensenta Pharmaceuticals Sterile Injectable CDMO Introduction
11.17.4 Gensenta Pharmaceuticals Revenue in Sterile Injectable CDMO Business (2019-2024)
11.17.5 Gensenta Pharmaceuticals Recent Development
11.18 BioTechnique
11.18.1 BioTechnique Company Details
11.18.2 BioTechnique Business Overview
11.18.3 BioTechnique Sterile Injectable CDMO Introduction
11.18.4 BioTechnique Revenue in Sterile Injectable CDMO Business (2019-2024)
11.18.5 BioTechnique Recent Development
11.19 Mithra CDMo
11.19.1 Mithra CDMo Company Details
11.19.2 Mithra CDMo Business Overview
11.19.3 Mithra CDMo Sterile Injectable CDMO Introduction
11.19.4 Mithra CDMo Revenue in Sterile Injectable CDMO Business (2019-2024)
11.19.5 Mithra CDMo Recent Development
11.20 S.C. Rompharm Company SRL
11.20.1 S.C. Rompharm Company SRL Company Details
11.20.2 S.C. Rompharm Company SRL Business Overview
11.20.3 S.C. Rompharm Company SRL Sterile Injectable CDMO Introduction
11.20.4 S.C. Rompharm Company SRL Revenue in Sterile Injectable CDMO Business (2019-2024)
11.20.5 S.C. Rompharm Company SRL Recent Development
11.21 Flagship Biotech International Pvt. Ltd
11.21.1 Flagship Biotech International Pvt. Ltd Company Details
11.21.2 Flagship Biotech International Pvt. Ltd Business Overview
11.21.3 Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Introduction
11.21.4 Flagship Biotech International Pvt. Ltd Revenue in Sterile Injectable CDMO Business (2019-2024)
11.21.5 Flagship Biotech International Pvt. Ltd Recent Development
11.22 Curida AS
11.22.1 Curida AS Company Details
11.22.2 Curida AS Business Overview
11.22.3 Curida AS Sterile Injectable CDMO Introduction
11.22.4 Curida AS Revenue in Sterile Injectable CDMO Business (2019-2024)
11.22.5 Curida AS Recent Development
11.23 BirgiMefar Group
11.23.1 BirgiMefar Group Company Details
11.23.2 BirgiMefar Group Business Overview
11.23.3 BirgiMefar Group Sterile Injectable CDMO Introduction
11.23.4 BirgiMefar Group Revenue in Sterile Injectable CDMO Business (2019-2024)
11.23.5 BirgiMefar Group Recent Development
11.24 Brooks Laboratories Limited
11.24.1 Brooks Laboratories Limited Company Details
11.24.2 Brooks Laboratories Limited Business Overview
11.24.3 Brooks Laboratories Limited Sterile Injectable CDMO Introduction
11.24.4 Brooks Laboratories Limited Revenue in Sterile Injectable CDMO Business (2019-2024)
11.24.5 Brooks Laboratories Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Famar
Pfizer Inc
Quotient Sciences
Temad
Tianjin Hankang Pharmaceutical Biotechnology
Fareva
Sharp
Astral SteriTech
Evonik
Aurigene Pharmaceutical Services
Ethypharm
TriRx Pharmaceutical Services
Gensenta Pharmaceuticals
Flagship Biotech International Pvt Ltd
Curida AS
Polfa Tarchomin
Prague Scientific
Biophrama Group
BioTechnique
Mithra CDMo
S.C. Rompharm Company SRL
BirgiMefar Group
Brooks Laboratories Limited
List of Tables
 Table 1. Global Sterile Injectable CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Preclinical Manufacturing
 Table 3. Key Players of Clinical Manufacturing
 Table 4. Key Players of Commercial Manufacturing
 Table 5. Global Sterile Injectable CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Sterile Injectable CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Sterile Injectable CDMO Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Sterile Injectable CDMO Market Share by Region (2019-2024)
 Table 9. Global Sterile Injectable CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Sterile Injectable CDMO Market Share by Region (2025-2030)
 Table 11. Sterile Injectable CDMO Market Trends
 Table 12. Sterile Injectable CDMO Market Drivers
 Table 13. Sterile Injectable CDMO Market Challenges
 Table 14. Sterile Injectable CDMO Market Restraints
 Table 15. Global Sterile Injectable CDMO Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Sterile Injectable CDMO Market Share by Players (2019-2024)
 Table 17. Global Top Sterile Injectable CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Injectable CDMO as of 2023)
 Table 18. Ranking of Global Top Sterile Injectable CDMO Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Sterile Injectable CDMO Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Sterile Injectable CDMO, Headquarters and Area Served
 Table 21. Global Key Players of Sterile Injectable CDMO, Product and Application
 Table 22. Global Key Players of Sterile Injectable CDMO, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Sterile Injectable CDMO Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Sterile Injectable CDMO Revenue Market Share by Type (2019-2024)
 Table 26. Global Sterile Injectable CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Sterile Injectable CDMO Revenue Market Share by Type (2025-2030)
 Table 28. Global Sterile Injectable CDMO Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Sterile Injectable CDMO Revenue Market Share by Application (2019-2024)
 Table 30. Global Sterile Injectable CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Sterile Injectable CDMO Revenue Market Share by Application (2025-2030)
 Table 32. North America Sterile Injectable CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Sterile Injectable CDMO Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Sterile Injectable CDMO Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Sterile Injectable CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Sterile Injectable CDMO Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Sterile Injectable CDMO Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Sterile Injectable CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Sterile Injectable CDMO Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Sterile Injectable CDMO Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Sterile Injectable CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Sterile Injectable CDMO Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Sterile Injectable CDMO Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Sterile Injectable CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Sterile Injectable CDMO Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Sterile Injectable CDMO Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Abbvie Company Details
 Table 48. Abbvie Business Overview
 Table 49. Abbvie Sterile Injectable CDMO Product
 Table 50. Abbvie Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 51. Abbvie Recent Development
 Table 52. Famar Company Details
 Table 53. Famar Business Overview
 Table 54. Famar Sterile Injectable CDMO Product
 Table 55. Famar Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 56. Famar Recent Development
 Table 57. Polfa Tarchomin Company Details
 Table 58. Polfa Tarchomin Business Overview
 Table 59. Polfa Tarchomin Sterile Injectable CDMO Product
 Table 60. Polfa Tarchomin Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 61. Polfa Tarchomin Recent Development
 Table 62. Pfizer Company Details
 Table 63. Pfizer Business Overview
 Table 64. Pfizer Sterile Injectable CDMO Product
 Table 65. Pfizer Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 66. Pfizer Recent Development
 Table 67. Quotient Sciences Company Details
 Table 68. Quotient Sciences Business Overview
 Table 69. Quotient Sciences Sterile Injectable CDMO Product
 Table 70. Quotient Sciences Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 71. Quotient Sciences Recent Development
 Table 72. Temad Co. Company Details
 Table 73. Temad Co. Business Overview
 Table 74. Temad Co. Sterile Injectable CDMO Product
 Table 75. Temad Co. Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 76. Temad Co. Recent Development
 Table 77. Tianjin Hankang Pharmaceutical Biotechnology Company Details
 Table 78. Tianjin Hankang Pharmaceutical Biotechnology Business Overview
 Table 79. Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Product
 Table 80. Tianjin Hankang Pharmaceutical Biotechnology Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 81. Tianjin Hankang Pharmaceutical Biotechnology Recent Development
 Table 82. Fareva Company Details
 Table 83. Fareva Business Overview
 Table 84. Fareva Sterile Injectable CDMO Product
 Table 85. Fareva Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 86. Fareva Recent Development
 Table 87. Sharp Company Details
 Table 88. Sharp Business Overview
 Table 89. Sharp Sterile Injectable CDMO Product
 Table 90. Sharp Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 91. Sharp Recent Development
 Table 92. Astral SteriTech Company Details
 Table 93. Astral SteriTech Business Overview
 Table 94. Astral SteriTech Sterile Injectable CDMO Product
 Table 95. Astral SteriTech Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 96. Astral SteriTech Recent Development
 Table 97. Evonik Company Details
 Table 98. Evonik Business Overview
 Table 99. Evonik Sterile Injectable CDMO Product
 Table 100. Evonik Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 101. Evonik Recent Development
 Table 102. Aurigene Pharmaceutical Services Company Details
 Table 103. Aurigene Pharmaceutical Services Business Overview
 Table 104. Aurigene Pharmaceutical Services Sterile Injectable CDMO Product
 Table 105. Aurigene Pharmaceutical Services Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 106. Aurigene Pharmaceutical Services Recent Development
 Table 107. Prague Scientific Company Details
 Table 108. Prague Scientific Business Overview
 Table 109. Prague Scientific Sterile Injectable CDMO Product
 Table 110. Prague Scientific Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 111. Prague Scientific Recent Development
 Table 112. Ethypharm Company Details
 Table 113. Ethypharm Business Overview
 Table 114. Ethypharm Sterile Injectable CDMO Product
 Table 115. Ethypharm Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 116. Ethypharm Recent Development
 Table 117. TriRx Pharmaceutical Services Company Details
 Table 118. TriRx Pharmaceutical Services Business Overview
 Table 119. TriRx Pharmaceutical Services Sterile Injectable CDMO Product
 Table 120. TriRx Pharmaceutical Services Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 121. TriRx Pharmaceutical Services Recent Development
 Table 122. Biophrama Group Company Details
 Table 123. Biophrama Group Business Overview
 Table 124. Biophrama Group Sterile Injectable CDMO Product
 Table 125. Biophrama Group Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 126. Biophrama Group Recent Development
 Table 127. Gensenta Pharmaceuticals Company Details
 Table 128. Gensenta Pharmaceuticals Business Overview
 Table 129. Gensenta Pharmaceuticals Sterile Injectable CDMO Product
 Table 130. Gensenta Pharmaceuticals Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 131. Gensenta Pharmaceuticals Recent Development
 Table 132. BioTechnique Company Details
 Table 133. BioTechnique Business Overview
 Table 134. BioTechnique Sterile Injectable CDMO Product
 Table 135. BioTechnique Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 136. BioTechnique Recent Development
 Table 137. Mithra CDMo Company Details
 Table 138. Mithra CDMo Business Overview
 Table 139. Mithra CDMo Sterile Injectable CDMO Product
 Table 140. Mithra CDMo Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 141. Mithra CDMo Recent Development
 Table 142. S.C. Rompharm Company SRL Company Details
 Table 143. S.C. Rompharm Company SRL Business Overview
 Table 144. S.C. Rompharm Company SRL Sterile Injectable CDMO Product
 Table 145. S.C. Rompharm Company SRL Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 146. S.C. Rompharm Company SRL Recent Development
 Table 147. Flagship Biotech International Pvt. Ltd Company Details
 Table 148. Flagship Biotech International Pvt. Ltd Business Overview
 Table 149. Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Product
 Table 150. Flagship Biotech International Pvt. Ltd Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 151. Flagship Biotech International Pvt. Ltd Recent Development
 Table 152. Curida AS Company Details
 Table 153. Curida AS Business Overview
 Table 154. Curida AS Sterile Injectable CDMO Product
 Table 155. Curida AS Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 156. Curida AS Recent Development
 Table 157. BirgiMefar Group Company Details
 Table 158. BirgiMefar Group Business Overview
 Table 159. BirgiMefar Group Sterile Injectable CDMO Product
 Table 160. BirgiMefar Group Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 161. BirgiMefar Group Recent Development
 Table 162. Brooks Laboratories Limited Company Details
 Table 163. Brooks Laboratories Limited Business Overview
 Table 164. Brooks Laboratories Limited Sterile Injectable CDMO Product
 Table 165. Brooks Laboratories Limited Revenue in Sterile Injectable CDMO Business (2019-2024) & (US$ Million)
 Table 166. Brooks Laboratories Limited Recent Development
 Table 167. Research Programs/Design for This Report
 Table 168. Key Data Information from Secondary Sources
 Table 169. Key Data Information from Primary Sources
 Table 170. Authors List of This Report


List of Figures
 Figure 1. Sterile Injectable CDMO Picture
 Figure 2. Global Sterile Injectable CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Sterile Injectable CDMO Market Share by Type: 2023 VS 2030
 Figure 4. Preclinical Manufacturing Features
 Figure 5. Clinical Manufacturing Features
 Figure 6. Commercial Manufacturing Features
 Figure 7. Global Sterile Injectable CDMO Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Sterile Injectable CDMO Market Share by Application: 2023 VS 2030
 Figure 9. Pharmaceutical Company Case Studies
 Figure 10. Research Institute Case Studies
 Figure 11. Other Case Studies
 Figure 12. Sterile Injectable CDMO Report Years Considered
 Figure 13. Global Sterile Injectable CDMO Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Sterile Injectable CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Sterile Injectable CDMO Market Share by Region: 2023 VS 2030
 Figure 16. Global Sterile Injectable CDMO Market Share by Players in 2023
 Figure 17. Global Top Sterile Injectable CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Injectable CDMO as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Sterile Injectable CDMO Revenue in 2023
 Figure 19. North America Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Sterile Injectable CDMO Market Share by Country (2019-2030)
 Figure 21. United States Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Sterile Injectable CDMO Market Share by Country (2019-2030)
 Figure 25. Germany Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Sterile Injectable CDMO Market Share by Region (2019-2030)
 Figure 33. China Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Sterile Injectable CDMO Market Share by Country (2019-2030)
 Figure 41. Mexico Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Sterile Injectable CDMO Market Share by Country (2019-2030)
 Figure 45. Turkey Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Sterile Injectable CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Abbvie Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 49. Famar Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 50. Polfa Tarchomin Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 51. Pfizer Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 52. Quotient Sciences Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 53. Temad Co. Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 54. Tianjin Hankang Pharmaceutical Biotechnology Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 55. Fareva Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 56. Sharp Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 57. Astral SteriTech Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 58. Evonik Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 59. Aurigene Pharmaceutical Services Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 60. Prague Scientific Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 61. Ethypharm Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 62. TriRx Pharmaceutical Services Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 63. Biophrama Group Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 64. Gensenta Pharmaceuticals Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 65. BioTechnique Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 66. Mithra CDMo Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 67. S.C. Rompharm Company SRL Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 68. Flagship Biotech International Pvt. Ltd Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 69. Curida AS Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 70. BirgiMefar Group Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 71. Brooks Laboratories Limited Revenue Growth Rate in Sterile Injectable CDMO Business (2019-2024)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025
Global Contract Dose Manufacturing Market Insights Forecast to 2030
Global Full Service CDMO Market Research Report 2024
Global Pharmaceutical CDMO Market Research Report 2025
Global Chemical CDMO Market Research Report 2024
Global Formulation CDMO Services Market Research Report 2024
Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biopharmaceutical CDMO Market Research Report 2025
Global Biopharmaceutical CDMO Service Market Research Report 2024
Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biopharmaceutical and Bio CDMO Market Research Report 2024
Global Chemical Drug CDMO Market Research Report 2024
Global Cell and Gene Therapy CDMO Services Market Research Report 2024
Global Specialty Chemicals CDMO Service Market Research Report 2024
Global Microbiome CDMO Market Research Report 2024
Pharmaceutical CDMO Services Market
Global Cell Therapy CDMO Services Market Research Report 2025
Global Bio Contract Development and Manufacturing Organizations CDMOs Market Insights Forecast to 2030
Pharmaceutical CDMO Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Topical Drugs CDMO Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions